C4 Therapeutics
NASDAQ: CCCCUnicorn · $1.8BCambridge, US · Founded 2015 · Delaware corporation · 5 known investors
Find your way into C4 Therapeutics
C4 Therapeutics develops targeted protein degradation medicines aimed at treating disease. The company works in the biotechnology and drug development space.
Founders & leadership
C4 Therapeutics was founded in 2015 by Kenneth C. Anderson.
KC
Kenneth C. AndersonFounder
AJ
Andrew J. HirschinPresident & CEO
Board
MC
JF
Jason FishermanBoard director
MS
Miles StuchinBoard director
BD
Bruce DowneyBoard director
BC
Bihua ChenBoard director
WM
William M. ScalzulliBoard director
MS
Malcolm S. SalterBoard director
JE
Jay EastmanBoard director
AC
EP
Elena ProkupetsBoard director
Investors · 5
Funding
SEC filings, press & company announcements$70.3M disclosed across 1 of 2 rounds · 2015–2020
- Undisclosed amountIPOOct 2020Source ↗
▶$70.3MraisedJan 2016 · 55 investors · BiotechnologyRule 506(b)
▶$70.3MraisedJan 2016 · 55 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Marc CohenExecutive Officer, Director
- Jason FishermanExecutive Officer, Director
- Miles StuchinDirector
- William M. ScalzulliDirector
- Kenneth AndersonDirector
- Malcolm S. SalterDirector
- Bruce DowneyDirector
- Jay EastmanDirector
- Alain CohenDirector
- Elena ProkupetsDirector
- Bihua ChenDirector
- Ronald W. KaiserDirector
- Offering amount
- $73.5M
- Amount sold
- $70.3M
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed events$1.8Bvaluation at IPOJun 2021 · $37.00/share · 424B4
filing ↗Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Competitors · 2
by search overlapKite Pharma84 shared keywordsKite develops CAR T-cell therapies that engineer a patient's own immune cells to target and destroy cancer cells. The company focuses on cell therapy treatments for cancers such as diffuse large B-cell lymphoma.
Robinhood53 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Companies competing with C4 Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
C4 Therapeutics Submits Q2 2026 Form 10-Q to SEC Detailing Financials and Collaborationskalkinemedia.com · Aug 2026Frequently asked questions
- What does C4 Therapeutics do?
- C4 Therapeutics develops targeted protein degradation medicines aimed at treating disease. The company works in the biotechnology and drug development space.
- Who founded C4 Therapeutics?
- C4 Therapeutics was founded by Kenneth C. Anderson in 2015.
- Who are C4 Therapeutics's investors?
- C4 Therapeutics's investors include 3E Bioventures Capital, Bain Capital Life Sciences, Nextech Invest, RA Capital, Cobro Ventures.
- How much funding has C4 Therapeutics raised?
- C4 Therapeutics has disclosed $70.3M raised across 1 of its 2 known rounds.
- Where is C4 Therapeutics headquartered?
- C4 Therapeutics is headquartered in Cambridge, US.